FindTrial
Sign In

Place de la Kétamine à dose anti-hyperalgésique dans l'épargne morphinique en réanimation. - KETAREA

Place de la Kétamine à dose anti-hyperalgésique dans l'épargne morphinique en réanimation. - KETAREA

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-022336-36-FR
Enrollment
Unknown
Registered
2011-09-22
Start date
2011-09-28
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: KETAMINE PANPHARMA 250 mg/5 ml Pharmaceutical Form: Solution for injection INN or Proposed INN: KETAMINE HYDROCHLORIDE CAS Number: 1867-66-9 Concentration unit: mg/ml milligram(s)/millilit

Sponsors

CHU de Clermont-Ferrand
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary end point(s): ;Main Objective: ;Secondary Objective:—

Countries

France

Contacts

Public ContactDélégation à la Recherche Clinique

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr330473751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026